A new study from the University of California, Davis, has uncovered how cells in the pancreas work together to stop blood sugar from dropping too low. This discovery could lead to better treatments ...
In a medical first, researchers report that they have implanted CRISPR-edited pancreas cells into a person with type 1 diabetes. The cells pumped out sugar-regulating insulin for months — without the ...
LONDON, Nov 14 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of ...
People with type 1 diabetes must constantly rely on insulin injections or pumps, usually for the rest of their life after diagnosis. The autoimmune disease destroys the cells that produce the hormone, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results